SELLAS Life Sciences (SLS) Prepaid Assets (2010 - 2026)
SELLAS Life Sciences' (SLS) quarterly Prepaid Assets came in at $4.0 million in Q1 2026, up 14.27% year-on-year from $3.5 million in Q1 2025, and up 19.71% on a QoQ basis from $3.3 million in Q4 2025.
SELLAS Life Sciences (SLS) Prepaid Assets (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 17 years of Prepaid Assets data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 14.27% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 14.27% increase from a year earlier, with the FY2025 full-year figure at $3.3 million, up 41.73% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.0 million, up from $3.3 million in the prior quarter.
- Over the last five years, Prepaid Assets for SLS reached as high as $4.6 million in Q3 2025 and fell as low as $531000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $2.5 million across 5 years, with a median of $2.5 million in 2022.
- Across the five-year window, Prepaid Assets plunged 66.58% in 2022 and surged 331.92% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $531000.0 in 2022, then climbed by 2.07% to $542000.0 in 2023, then jumped by 331.92% to $2.3 million in 2024, then surged by 41.73% to $3.3 million in 2025, then grew by 19.71% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $4.0 million in Q1 2026, $3.3 million in Q4 2025, and $4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.97 Mn |
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 4.05 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 542,000.00 |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 531,000.00 |
| Sep 30, 2022 | 1.16 Mn |
| Jun 30, 2022 | 1.65 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | 2.32 Mn |